Inventor

JIAXIN YU

Inventor
US

Overview

14→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 14 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations30%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes23%
C07KPeptides3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms3%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
H04LTransmission of digital information, e.g. telegraphic communication3%
H04WWireless communication networks3%
Y02DClimate change mitigation technologies in information and communication technologies [ict], i.e. information and communication technologies aiming at the reduction of their own energy use3%

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to RIGEL PHARMACEUTICALS INC (11)· patent assignee history
2022Patents assigned to BRISTOL MYERS SQUIBB CO (1)· patent assignee history
2022–2025Based in US· patent location history
2022Based in TW· patent location history
2024Patents assigned to LILLY CO ELI (1)· patent assignee history
2025Patents assigned to CURASEN THERAPEUTICS INC (1)· patent assignee history
2025Patents assigned to HUAWEI TECH CO LTD (1)· patent assignee history
2025Based in CN· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
RIGEL PHARMACEUTICALS INC112022–2025
BRISTOL MYERS SQUIBB CO12022
CURASEN THERAPEUTICS INC12025
HUAWEI TECH CO LTD12025
LILLY CO ELI12024
Locations
LocationPatentsSpan
US122022–2025
CN12025
TW12022